Susquehanna International Group’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.09M | Buy |
241,970
+132,559
| +121% | +$580K | ﹤0.01% | 7663 |
|
|
2025
Q4 | $526K | Buy |
109,411
+45,219
| +70% | +$203K | ﹤0.01% | 8666 |
|
|
2025
Q3 | $291K | Sell |
64,192
-155,236
| -71% | -$570K | ﹤0.01% | 10174 |
|
|
2025
Q2 | $678K | Sell |
219,428
-182,933
| -45% | -$607K | ﹤0.01% | 8447 |
|
|
2025
Q1 | $1.4M | Buy |
402,361
+287,139
| +249% | +$958K | ﹤0.01% | 6378 |
|
|
2024
Q4 | $377K | Buy |
115,222
+10,283
| +10% | +$37.8K | ﹤0.01% | 9332 |
|
|
2024
Q3 | $404K | Sell |
104,939
-462,029
| -81% | -$1.77M | ﹤0.01% | 8976 |
|
|
2024
Q2 | $1.75M | Buy |
566,968
+532,033
| +1,523% | +$1.6M | ﹤0.01% | 5349 |
|
|
2024
Q1 | $90.1K | Sell |
34,935
-157,146
| -82% | -$407K | ﹤0.01% | 11278 |
|
|
2023
Q4 | $480K | Sell |
192,081
-16,356
| -8% | -$32K | ﹤0.01% | 8768 |
|
|
2023
Q3 | $423K | Sell |
208,437
-103,050
| -33% | -$216K | ﹤0.01% | 8620 |
|
|
2023
Q2 | $716K | Buy |
311,487
+147,592
| +90% | +$384K | ﹤0.01% | 7462 |
|
|
2023
Q1 | $497K | Sell |
163,895
-130,651
| -44% | -$369K | ﹤0.01% | 8581 |
|
|
2022
Q4 | $686K | Buy |
294,546
+4,984
| +2% | +$11.9K | ﹤0.01% | 7070 |
|
|
2022
Q3 | $553K | Buy |
289,562
+4,137
| +1% | +$9.74K | ﹤0.01% | 8213 |
|
|
2022
Q2 | $774K | Sell |
285,425
-155,240
| -35% | -$397K | ﹤0.01% | 7161 |
|
|
2022
Q1 | $1.31M | Sell |
440,665
-76,250
| -15% | -$233K | ﹤0.01% | 6454 |
|
|
2021
Q4 | $2.01M | Sell |
516,915
-145,688
| -22% | -$566K | ﹤0.01% | 5484 |
|
|
2021
Q3 | $2.84M | Buy |
662,603
+404,726
| +157% | +$1.35M | ﹤0.01% | 5069 |
|
|
2021
Q2 | $781K | Sell |
257,877
-411,234
| -61% | -$1.27M | ﹤0.01% | 8442 |
|
|
2021
Q1 | $2.23M | Buy |
669,111
+264,748
| +65% | +$1.02M | ﹤0.01% | 5662 |
|
|
2020
Q4 | $1.44M | Buy |
404,363
+204,425
| +102% | +$716K | ﹤0.01% | 5838 |
|
|
2020
Q3 | $626K | Buy |
+199,938
| New | +$608K | ﹤0.01% | 7201 |
|
|
2020
Q2 | – | Sell |
-169,908
| Closed | -$278K | – | 10024 |
|
|
2020
Q1 | $172K | Buy |
169,908
+105,662
| +164% | +$286K | ﹤0.01% | 8864 |
|
|
2019
Q4 | $179K | Buy |
64,246
+51,265
| +395% | +$82.9K | ﹤0.01% | 8842 |
|
|
2019
Q3 | $20K | Sell |
12,981
-27,617
| -68% | -$47.6K | ﹤0.01% | 9947 |
|
|
2019
Q2 | $84K | Buy |
+40,598
| New | +$104K | ﹤0.01% | 9677 |
|
|
2018
Q1 | – | Sell |
-19,099
| Closed | -$101K | – | 9222 |
|
|
2017
Q4 | $96K | Sell |
19,099
-3,421
| -15% | -$20.1K | ﹤0.01% | 8707 |
|
|
2017
Q3 | $140K | Sell |
22,520
-7,959
| -26% | -$34K | ﹤0.01% | 8231 |
|
|
2017
Q2 | $110K | Buy |
30,479
+16,107
| +112% | +$55.4K | ﹤0.01% | 8643 |
|
|
2017
Q1 | $47K | Sell |
14,372
-55,967
| -80% | -$155K | ﹤0.01% | 8609 |
|
|
2016
Q4 | $172K | Buy |
70,339
+55,636
| +378% | +$162K | ﹤0.01% | 8769 |
|
|
2016
Q3 | $51K | Buy |
14,703
+4,079
| +38% | +$15.9K | ﹤0.01% | 8116 |
|
|
2016
Q2 | $37K | Sell |
10,624
-1,811
| -15% | -$7.67K | ﹤0.01% | 8290 |
|
|
2016
Q1 | $51K | Buy |
+12,435
| New | +$44.4K | ﹤0.01% | 8659 |
|
|
2015
Q4 | – | Sell |
-41,482
| Closed | -$227K | – | 9345 |
|
|
2015
Q3 | $253K | Buy |
41,482
+1,368
| +3% | +$12.1K | ﹤0.01% | 8319 |
|
|
2015
Q2 | $476K | Buy |
+40,114
| New | +$610K | ﹤0.01% | 7728 |
|
|
2015
Q1 | – | Sell |
-95,301
| Closed | -$1.95M | – | 9339 |
|
|
2014
Q4 | $1.44M | Sell |
95,301
-120,560
| -56% | -$2.08M | ﹤0.01% | 5106 |
|
|
2014
Q3 | $4.56M | Buy |
+215,861
| New | +$3.52M | ﹤0.01% | 3154 |
|
|
2014
Q2 | – | Sell |
-11,320
| Closed | -$160K | – | 9706 |
|
|
2014
Q1 | $243K | Buy |
+11,320
| New | +$203K | ﹤0.01% | 7929 |
|
Other funds holding ABUS
TSC
WCM
VCM
RCMNY
ACM